Pyrrolizidine alkaloids (PA)
Well-established toxicology from animal studies and human case reports of hepatotoxicity and cirrhosisMechanism of Action
Research Notes
Well-established hepatotoxicity and carcinogenicity from in vivo studies and human case reports. Cumulative dose and duration determine toxicity. Individual metabolic factors affect susceptibility. Risk increases with repeated or prolonged exposure. Vulnerable populations (pregnancy, liver disease, children) at higher risk. Genetic polymorphisms in PA metabolism may create individual susceptibility variation.
Found In 1 Herb
3D Molecular Structure
Pyrrolizidine alkaloids (PA)
Representative pattern: C₉H₇N₂O
Live Research
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.
